StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by kaos12on Mar 18, 2019 1:13pm

178 Views

Post# 29501270

Doji’s!

The three dojis we saw in the last six trading days essentially was investors undecided as bulls and bears were equal. I wonder if financials being announced April 1 is a bit of a catalyst for FOMO and investors are looking very bullishly at GEN. if we break .21 I think we will be looking at .42 for a target. Now wouldn’t THAT be nice? I can’t see myself selling ANY shares before a buck. GLTA.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?